Medical Faculty, University of Cologne, Institute of Legal Medicine, Cologne, Germany.
Department of Forensic Medicine and Clinical Toxicology, Faculty of Medicine, Assiut University, Assiut, Egypt.
Int J Legal Med. 2017 Nov;131(6):1597-1613. doi: 10.1007/s00414-017-1632-4. Epub 2017 Jul 17.
Sudden infant death syndrome (SIDS) remains one of the most common causes of post-neonatal infant mortality in developed countries. Its pathogenesis is still poorly understood. The goal of the present study was to characterize changes in the proteome of SIDS compared to age-matched controls in heart and medulla tissues as well as in blood samples using two complementary quantitative proteomic techniques: 2D-DIGE and iTRAQ aiming to provide new insights into the mechanism of SIDS and to find diagnostic protein patterns. Our results revealed collectively 122 modulated proteins in SIDS of which 83 proteins were up-regulated. They are involved in metabolic processes, cellular processes, and localization. Gene expression patterns of selected proteins were further validated by reverse transcription quantitative real-time PCR (RT-qPCR). The role of hypoxia, inflammation, and apoptosis in SIDS was demonstrated by exploring some candidate proteins especially APOA1, GAPDH, S100B, zyxin, and complement component C4A. According to the results of this study, these proteins might be used as diagnostic biomarkers for SIDS. All of them were up-regulated in SIDS except for C4A that was down-regulated.
婴儿猝死综合征(SIDS)仍然是发达国家新生儿后死亡的最常见原因之一。其发病机制仍不清楚。本研究的目的是使用两种互补的定量蛋白质组学技术:2D-DIGE 和 iTRAQ,比较 SIDS 与年龄匹配的对照组在心脏和延髓组织以及血液样本中的蛋白质组变化,旨在提供对 SIDS 机制的新见解,并寻找诊断蛋白质模式。我们的结果共揭示了 122 种在 SIDS 中调节的蛋白质,其中 83 种蛋白质上调。它们涉及代谢过程、细胞过程和定位。通过探索一些候选蛋白质,特别是 APOA1、GAPDH、S100B、zyxin 和补体成分 C4A,进一步验证了选定蛋白质的基因表达模式。通过探索一些候选蛋白质,特别是 APOA1、GAPDH、S100B、zyxin 和补体成分 C4A,进一步验证了选定蛋白质的基因表达模式。通过探索一些候选蛋白质,特别是 APOA1、GAPDH、S100B、zyxin 和补体成分 C4A,进一步验证了选定蛋白质的基因表达模式。这些蛋白质可能被用作 SIDS 的诊断生物标志物。除了下调的 C4A 外,所有这些蛋白质在 SIDS 中均上调。